Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Emmaus Life Sciences, Inc. | s111899_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Emmaus Life Sciences, Inc. | s111899_ex31-1.htm |
| EX-10.2 - EXHIBIT 10.2 - Emmaus Life Sciences, Inc. | s111899_ex10-2.htm |
| 10-Q - FORM 10-Q - Emmaus Life Sciences, Inc. | s111899_10q.htm |
EXHIBIT 32.1
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 (the “Report”) by MYnd Analytics, Inc. (the “Registrant”), the undersigned hereby certifies that in his capacity as an officer of the Registrant that to his knowledge:
| 1. | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
| Date: August 10, 2018 | /s/ George C. Carpenter IV |
| George C. Carpenter IV | |
| Chief Executive Officer (Principal Executive Officer) | |
| Date: August 10, 2018 | /s/ Donald D’Ambrosio |
| Donald D’Ambrosio | |
| Chief Financial Officer (Principal Financial Officer) |